Legal & General Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.4M Buy
727,564
+47,395
+7% +$677K ﹤0.01% 1160
2025
Q1
$7.14M Buy
680,169
+24,205
+4% +$254K ﹤0.01% 1332
2024
Q4
$7.94M Sell
655,964
-26,466
-4% -$321K ﹤0.01% 1313
2024
Q3
$10M Buy
682,430
+9,875
+1% +$145K ﹤0.01% 1172
2024
Q2
$9.7M Buy
672,555
+94,335
+16% +$1.36M ﹤0.01% 1144
2024
Q1
$9.41M Sell
578,220
-16,976
-3% -$276K ﹤0.01% 1182
2023
Q4
$8.87M Buy
595,196
+45,782
+8% +$682K ﹤0.01% 1202
2023
Q3
$6.18M Sell
549,414
-1,046,762
-66% -$11.8M ﹤0.01% 1323
2023
Q2
$16.1M Sell
1,596,176
-604,002
-27% -$6.08M 0.01% 905
2023
Q1
$20.7M Sell
2,200,178
-124,336
-5% -$1.17M 0.01% 805
2022
Q4
$28.4M Sell
2,324,514
-292,235
-11% -$3.57M 0.01% 730
2022
Q3
$32.5M Sell
2,616,749
-125,523
-5% -$1.56M 0.01% 703
2022
Q2
$53.8M Buy
2,742,272
+9,874
+0.4% +$194K 0.02% 622
2022
Q1
$71.3M Buy
2,732,398
+427,572
+19% +$11.2M 0.02% 602
2021
Q4
$65.4M Sell
2,304,826
-183,983
-7% -$5.22M 0.02% 630
2021
Q3
$79.4M Sell
2,488,809
-11,674
-0.5% -$372K 0.03% 589
2021
Q2
$86.7M Sell
2,500,483
-479,939
-16% -$16.6M 0.03% 570
2021
Q1
$87.8M Sell
2,980,422
-15,084
-0.5% -$444K 0.03% 540
2020
Q4
$91.9M Buy
2,995,506
+346,791
+13% +$10.6M 0.04% 504
2020
Q3
$74M Buy
2,648,715
+62,142
+2% +$1.74M 0.03% 503
2020
Q2
$55.5M Buy
2,586,573
+151,487
+6% +$3.25M 0.03% 545
2020
Q1
$54.6M Buy
2,435,086
+204,711
+9% +$4.59M 0.03% 495
2019
Q4
$65.7M Buy
2,230,375
+184,933
+9% +$5.45M 0.03% 536
2019
Q3
$54.4M Buy
2,045,442
+71,016
+4% +$1.89M 0.03% 555
2019
Q2
$66.8M Buy
1,974,426
+462,333
+31% +$15.6M 0.04% 507
2019
Q1
$48.5M Buy
1,512,093
+1,443,257
+2,097% +$46.3M 0.03% 570
2018
Q4
$2.17M Buy
68,836
+44,836
+187% +$1.41M ﹤0.01% 1543
2018
Q3
$839K Buy
+24,000
New +$839K ﹤0.01% 2000